This week the headline appeared to have some tough news for RNA companies, but Alnylam remains undeterred about the potential of its treatments.» Read More
Global healthcare company Roche is confident of growth in emerging markets despite the economic slowdown.
Jan 13- Lexicon Pharmaceuticals Inc said its chief executive would leave and it would cut its workforce by about 45 percent, as it moves its focus away from drug discovery to completing the studies of its drugs in late-stage development. The company said Arthur Sands, CEO since 1995 and a co-founder, intends to develop a succession plan with the board.
But the delay in packaging the liquid version has not affected supplies of regular Tamiflu, said the Roche unit that makes the medication.
Jan 9- In what is shaping up to be a tough and widespread flu season in the United States, one of the leading medicines used to treat children with the sometimes deadly virus is in short supply.
Private equity firm Carlyle Group is nearing an agreement to acquire a Johnson & Johnson unit, people familiar with the matter said.
European equities closed lower on Tuesday as investors remained cautious over the timing of the Fed's reduction of its stimulus program.
CHICAGO, Dec 9- There is a growing consensus that U.S. stocks, as well as stocks around the world, are going to catch a tailwind going into 2014.. The Vanguard Total World Stock Index ETF owns more than 5,000 stocks, but has its top holdings in mega-cap American companies like Apple Inc, Exxon Mobil Corp and Google Inc..
Dec 8- An experimental AbbVie Inc drug for leukemia controlled or eliminated signs of the disease in more than 80 percent of patients who had failed to benefit from previous treatments, an unprecedented finding that could spur use of the medicine for other cancers, researchers said.
Dec 3- Patients who are being treated for a leading cause of blindness among the elderly might be able to scale back on eye injections if trials confirm the potential of an eye drop being developed by a small New York- based company.
Nov 27- President Barack Obama signed a bill into law on Wednesday that gives U.S. health regulators greater oversight of bulk pharmaceutical compounding and strengthens their ability to track drugs through the distribution pipeline.
GlaxoSmithKline's pharmaceutical and vaccine sales to China tumbled 61 percent in the third quarter, with the drugmaker hit by an ongoing bribery investigation.
European equities closed narrowly higher on Thursday, with investors underwhelmed by U.S. lawmakers finally reaching a deal to lift the country's borrowing limit.
Emerging markets still offer room for growth, Roche's CEO told CNBC after the pharma posted an 8 percent increase in third-quarter sales.
With Washington's debt battle over, markets will quickly shift focus to earnings and how much the government shutdown actually impacted the economy.
Andrew Weiss, head of pharma and biotech research at Vontobel, says Roche's plan reflects the Swiss pharmaceutical giant's strong pipeline.
German airline Deutsche Lufthansa announced its largest-ever aircraft order on Thursday, worth 14 billion euros ($19.0 billion).
Verizon Communications priced a massive bond sale on Wednesday, offering $49 billion worth of debt.
The FDA is expected to decide on whether to fast track Perjeta for early treatment of breast cancer by Oct. 31.
As resources move to other areas, cardiologists fear the battle against heart disease could stall after advances marked by critical drugs to lower cholesterol and blood pressure.
The investment bank highlights eight industry themes it describes as "creative destruction" - trends that make it necessary for companies to either "adapt or die."